Category: hand hygiene

Are there problems with alcohol gel?

Prisoners get drunk on alcohol hand-gel. Many Muslims can’t even use it. Alcohol hand-gel should be “a thing of the past.”

Healthcare experts gathered in Harrogate last week for a conference hosted by the Infection Prevention Society, the leading medical conference in the field of infection control.

Groundbreaking research was presented to the conference that suggests alcohol-based hand cleaners are no longer the most effective first line of defence in infection prevention.

Alcohol-based hand gels have several significant drawbacks, which have led manufacturers to invest heavily in finding a safer, easier and more effective hand sanitizers.

One such manufacturer is Q Technologies Group, who have set themselves the task of leading a “hygiene revolution.” This revolution has already started in China were Q Shield hand foam has recently passed through all regulatory requirements.

Q Shield hand-foam, based on new “micro-polymer’’ technology, has been proven to demonstrate superior protection against the swine flu virus, and is unique as it delivers long lasting anti microbial protection compared to alcohol based products which stop working as soon as they dry.

Charlie Pillans, the company’s Managing Director, developed their water-based hand-foam that actually out-performs leading alcohol hand-washes in killing and preventing the germs which cause swine flu and hospital superbugs.

Mr Pillans says “Alcohol hand-washes have run their course. They are no longer the most effective products. Nurses complain of dry and damaged skin caused by alcohol hand gel, prisoners are getting drunk on the stuff, many Muslims can’t touch alcohol and, to top it all, it isn’t even very effective when you consider that it stops working as soon as it evaporates – which is almost immediately.”

Q Shield’s micro-polymer technology forms an invisible protective layer on any surface, be it human hands or a hospital floor. Independent laboratory tests have demonstrated Q Shield’s effectiveness in killing the flu viruses and have also shown that Q Shield kills viruses for at least 24 hours after application to hard surfaces – unlike conventional disinfectants which stop working when dry.

Lord Warner, the former government Health Minister, has been quoted as saying “The scientific evidence proves that persistent products mark a step-change in the fight against the swine flu pandemic. The long-lasting nature of the product, combined with its safety, means that persistent hygiene products have the potential to revolutionise the way we deal with flu and superbugs.”

Preventing the Spread of Infection in Schools

The CDC posts influenza prevention and response guidelines for schools and school nurses, for each educational level. The CDC’s latest K-12 recommendations for situations with severity similar to that of the spring 2009 outbreak include:

Staying home when sick. Any student or staff member who comes down with flu-like illness should be sent home and stay at home for at least 24 hours after they no longer have a fever, or signs of a fever, without the use of fever-reducing medicines. They should stay home even if they are taking antiviral drugs. The most common signs of influenza are fever (temperature > 100 degrees F), sore throat, and coughing. Headache and weakness have also been reported.

Using hand hygiene and respiratory etiquette. These are the first lines of defense against influenza. Everyone should wash hands frequently with soap and running water when possible, and cover noses and mouths with a tissue when coughing or sneezing (or a shirt sleeve or elbow if no tissue is available). Hand sanitizer should be widely available, especially in areas where there is no running water.

Separating ill students and staff. Students who appear to have flu-like illness should wait in a room separate from healthy students until they can be sent home. The CDC recommends that the ill student wear a surgical mask and be placed in a separate room. School nurses and health room attendants should wear protective gear, such as a mask, when in contact with a sick child or staff member.

Initiating early treatment of high-risk students and staff. Students or staff at high risk for influenza complications who present with influenza-like illness should contact their healthcare provider as soon as possible. Early treatment with antiviral medications is very important for people at high risk because it can prevent hospitalizations and deaths. People at high risk include those who are pregnant, have asthma or diabetes, have compromised immune systems, or have neuromuscular diseases.

Routine cleaning. School staff should routinely clean areas that students and staff touch often with the cleaners they typically use. The CDC does not believe that any additional disinfection of environmental surfaces beyond the recommended routine cleaning is required.

Considering school dismissal. School dismissal might be necessary for select schools. For example, a community might decide to dismiss a school that has a large population of high-risk students to better protect the high-risk students.

These recommendations could change if we encounter influenza conditions with increased severity compared with spring of 2009. Supplementary measures might include active screening of students, telling high-risk staff and students to stay home (even if they are not symptomatic), telling students with ill household members to stay home for 5 days after the first person became ill, increasing the distance between students, and extending the period for ill students to stay home to 7 days. If a school closure is necessary, the school should remain open to staff so that they can continue to provide instruction by other means.

School closure has a ripple effect throughout the community. The benefits of reducing illness and complications of influenza can be rapidly outweighed by negative consequences, including students being left home alone, healthcare workers missing shifts when they must stay home with their children, students missing meals, and interruption of students’ education.

“School closure will be a local decision, unless the pattern of illness increases in severity,” explains Delack. “Right now, the only reason to close a school is if you have so many staff home sick that you can’t staff the school.” She also contends that if schools are closed, students need to stay home, acknowledging that this poses problems for parents who are working. Delack recommends telling parents at the beginning of the school year that they need to make contingency plans for childcare should the schools close or their children become ill.

If conditions are more severe than they were last spring, there is a greater chance that school closure will occur as schools find themselves unable to maintain normal functioning (a reactive dismissal). Alternatively, preemptive dismissals could be recommended if the flu is causing more severe disease than expected. If a decision is made to close one or more schools, this must be reported to the CDC via the Novel Influenza A (H1N1) — Related School Dismissal Reporting system. An online reporting form is available.

The H1N1 Vaccine
Current projections of vaccine supply indicate that, at least initially, 5 specific groups will be targeted for vaccination when the vaccine becomes available. These are

  • Pregnant women;
  • Persons who live with or provide care for infants age < 6 months (eg, parents, siblings, and daycare providers);
  • Healthcare and emergency medical services personnel;
  • Persons age 6 months to 24 years; and
  • Persons age 25-64 years who have medical conditions that put them at higher risk for influenza-related complications.

If the vaccine supply is even more limited than expected, the most vulnerable of these 5 groups (eg, pregnant women, persons with medical conditions that connote high risk) will be vaccinated first. Therefore, in a setting of extremely limited availability of vaccine, school-age children (age 5-18 years) who are otherwise healthy would not be among the first recipients of the vaccine. All children, however, should receive the seasonal influenza vaccination as soon as it becomes available.

The news is full of reports that the US government and many state departments of health are gearing up for mass vaccinations of students within the schools, much like the mass polio vaccinations of students in the 1960s. Although no definitive decisions regarding dissemination of the vaccine to students have yet been made, Delack believes that schools are the “logical choice” to serve as vaccination clinics. In any case, mass vaccinations of healthy, low-risk students and staff may be a long way off according to other reports suggesting that only about one third of the needed supply of vaccine will be available in October 2009.

Conclusion
In their issue brief, “Role of the School Nurse,” the NASN notes that in 1902, the earliest function of school nurses was “to reduce absenteeism by intervening with students and families regarding health care needs related to communicable diseases.” Although in subsequent years the role of the school nurse has expanded far beyond this responsibility, it seems that in 2009 we have come full circle. The school nurse must assume a leadership role in the prevention of a pandemic influenza, a role that involves education, collaboration, planning, decision-making, and many other functions. Schools that have nurses should consider themselves very lucky in the days and weeks to come.

About the NASN. The NASN is the leader in advocacy for student health and professional development of school nurses. The Association supports the health and educational success of children and youth by developing and providing leadership to advance school nursing practice by specialized registered nurses. Every child deserves a school nurse.

Hospital hand wash gels ‘unreliable’

Disinfectant gels recently introduced in UK hospitals may not be reliable for hand hygiene and could contribute to ward infections, research suggests. They are said to be less effective than both disinfectant rinses and soap and water.
The gels were introduced because they caused less skin irritation, were quicker to administer, and were thought to encourage hygiene compliance.

Hand hygiene among health-care workers is a major priority to prevent the spread of infection in hospitals.

The introduction of any of the tested gels would be a backward step and unnecessarily lower the hygiene standard

Professor Didier Pittet, research co-ordinator
Researchers from Switzerland and Germany carried out research on 10 alcohol-based gels and four alcohol-based hand rinses and compared them to a reference disinfectant.
The reference disinfectant, derived from propanol, complies with European antiseptic standards known as EN 1500.
According to the research, published in The Lancet, none of the gel formulations, most of which were ethanol-based, were as effective as the reference disinfectant within 30 seconds of application.

Contamination risk

All of the hand rinses were equally as effective as the reference disinfectant.

The researchers concluded the hand gels should not be used to replace alcohol-based liquid rinses.
Research co-ordinator Professor Didier Pittet said: “In hospitals where most health-care workers use alcohol-based solutions that already meet the EN 1500 requirements, the introduction of any of the tested gels would be a backward step and unnecessarily lower the hygiene standard.

“An increased risk of cross-transmission would certainly result because the application time in daily practice averages eight to 15 seconds and is unlikely to exceed 30 seconds.”

Two brands tested in the survey – Levermed and Spirigel – are used in UK hospitals.
Guy’s and St Thomas’ hospitals in London use both gels and handwashes, but stress the gels are used only in very specific circumstances.

A hospital trust spokeswoman said: “Gels are used where staff are going between one patient and another and would not come into contact with blood or bodily fluids.

“If they have come into contact with blood or fluid then they should wash with liquid hand wash.”

Guidelines on Management of 2009 H1N1 Influenza – Swine Flu

September 9, 2009 — The US Centers for Disease Control and Prevention (CDC) have updated its guidelines on the reporting and management of the 2009 influenza A (H1N1) virus, according to a media briefing yesterday.

Topics covered include characteristics of 2009 H1N1 influenza based on ongoing surveillance and guidance regarding use of antiviral agents for 2009 H1N1 influenza and seasonal influenza.

Although the recommended drugs and groups of patients requiring antiviral treatment remain unchanged from the previous update, the latest recommendations include a “watchful waiting” option for prophylaxis and emphasize the need for prompt treatment in high-risk patients.

“The 2009 H1N1 influenza virus] never went away this summer — it’s still around, and we need to pay attention,” said Anne Schuchat, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases. “The good news is that the spectrum of illness doesn’t seem to have changed, but we really don’t know what the trajectory will be. Our principal prediction is that it will be a busy and long season, and we need to be prepared.”

The most recent increase in 2009 H1N1 influenza activity appears to be centered in the southeastern states, including Georgia, Mississippi, Alabama, and Florida. On September 4, 24 primary and secondary schools in Georgia, Indiana, Missouri, and Tennessee announced that they had sent home a total of 25,000 students with flu-like illness thought to be caused by the H1N1 strain. The reason for this geographic predilection is unclear, but 2 important factors may be that schools in the southeastern states resume classes earlier than do schools in other regions and that the southeastern states had relatively less H1N1 activity in the spring.

“We expect more variability in the H1N1 virus going into next spring,” Dr. Schuchat said. “But the good news is that the virus is unchanged in its appearance so far, so that the vaccines that have been prepared against this strain should still be effective.”

Compared with CDC guidance issued on May 6, 2009, the latest guidance differs in the following ways:
Additional context and guidance for clinicians is provided to help ensure that antiviral drugs are prescribed appropriately this season and that they are administered quickly to those in greatest need. As before, the priority for use of antiviral drugs is for patients who are hospitalized with influenza-like illness and for those patients who are ill with influenza-like illness and who are at high risk for influenza-related complications.
To shorten possible delays between illness onset in high-risk patients and treatment, clinicians should consider providing prescriptions for antiviral medications ahead of time for such patients. Should the patient develop symptoms, he or she could call the clinician for guidance about whether to fill the prescription.
More information is given concerning the appropriate (and limited) situations in which antiviral medications should be used for chemoprophylaxis. Antiviral agents should not be used for prevention in healthy persons based on community exposures. Rather than immediately treat all persons at high risk who have been exposed to H1N1, it may be appropriate in some closely monitored patients to watch expectantly, giving antiviral agents immediately if symptoms develop, but not as prophylaxis in asymptomatic individuals.
The new recommendations emphasize using antiviral drugs for early treatment instead of for prophylaxis to provide clinicians with the information needed to reach those at greatest risk with appropriate and timely treatment, to lower the risk of developing antiviral resistance, and to recognize the importance of clinical judgment in making patient-specific decisions regarding treatment and chemoprophylaxis.
Thus far, there have been “only a handful” of cases of reported H1N1 resistance to antiviral agents, according to Dr. Schuchat.

As the CDC recommended previously, all persons with suspected or confirmed influenza requiring hospitalization should be treated with oseltamivir or zanamivir, as should those who are at increased risk for complications (children younger than 5 years, adults aged 65 years and older, pregnant women, persons with certain chronic medical or immunosuppressive conditions, and persons younger than 19 years who are receiving long-term aspirin therapy).

“Timing of antiviral therapy is important, and it should be started in high-risk patients within 48 hours of symptom onset,” Dr. Schuchat said. “But clinical judgment is still important, and we want clinicians to customize their care for each patient.”

The latest guidelines emphasize starting treatment as early as possible in hospitalized patients or in those at high risk for complications, because studies have shown that treatment started within 48 hours of illness onset is more likely to provide benefit.

Treatment should not be delayed pending laboratory confirmation of influenza, because a negative rapid test for influenza does not rule out influenza and sensitivity ranges from 10% to 70%.
In addition to hospitalized patients and those at high risk for complications, any patient with suspected influenza presenting with warning symptoms or signs should promptly receive empiric antiviral treatment. These “red flag” findings include dyspnea, tachypnea, fever, unexplained oxygen desaturation, and/or lower respiratory tract illness.
Clinicians should educate their patients about these warning symptoms and encourage them to seek treatment as soon as possible if the symptoms are present. In infants and young children, additional warning signs are lethargy, irritability to the point of not wanting to be held, and symptoms initially appearing to improve and then getting worse.
Persons who are not at higher risk for complications or do not have severe influenza requiring hospitalization generally do not require antiviral medications for treatment or prophylaxis.
“Antivirals are a critical part of our tool kit in countering influenza, both H1N1 and other strains,” Dr. Schuchat said. “But a key point is that most children, adolescents, and adults do not need antiviral medication if they develop a flu-like illness. Giving these medications when they are not needed could actually make things worse by promoting viral resistance.”
The reporting and management guidelines are available on the CDC’s H1N1 Flu Clinical and Public Health Guidance page.

A Dorset prison has removed anti-bacterial hand gel pumps

A Dorset prison has removed anti-bacterial hand gel pumps, which contain alcohol, after an inmate reportedly got drunk on them.

The gel was made available on Monday at HMP The Verne in Portland to help combat the spread of swine flu.

But the Prison Officers Association (POA) said within hours there had been an incident with an intoxicated inmate.

The Prison Service said the pumps were removed as a “precautionary measure” and an investigation was under way.

It is believed the gel was mixed with a drink before it was consumed.

In March, Royal Bournemouth Hospital said it was one of many hospitals removing alcohol-based hand cleaning gel from reception areas in a bid to stop visitors drinking it.

Andy Fear, from the POA at The Verne, said: “We were informed of an incident within hours of the gel being available.

“In one of the wings it is believed an inmate was using it inappropriately.

“When you get something called alcohol gel you can see what is going to happen.

“We had concerns when we heard these were being given to inmates.

“You don’t want drunk prisoners running around the prison.”

A Prison Service spokesman added: “On 21 September a prisoner at HMP The Verne showed signs of intoxication, the cause of which will be investigated.

“Anti-bacterial hand gel pumps have been removed from the prison as a precautionary measure.”

The BBC understands reports that there was a fight between inmates during the incident are incorrect.

Source:
BBC

Q Shield™ used by leading weight loss surgery clinic in the UK

Gateway Health one of the UK’s premier Gastric Band and Gastric Balloon clinics has announced today that all clinical and administration staff throughout the country will be using QShield. A spokesperson for Gateway Health commented

” As health care professionals we see the use of Q Shield™ hand sanitizer as part of our duty of care to patients and staff alike”

Buy Q Shield Online

Q Shield working with:

NHS hand santizer BMI Hand Santizer
Ramsay Health Hand Santizer from QShield Hand Sanitizer QShield at BMW
Management trust use Hand Sanitizer from QShield

Hand Santizers important to optical express
Help, Teddy's got a bug: The (very) alarming results when one family asked a science lab to test their home for germs
Read more...

Q Shield in Ireland

In order to provide a better service to business customers in Ireland QShield are pleased to confirm the appointment of John Bannon as distributors